Home › Funds › TRV GP IV, LLC › TNGX
TRV GP IV, LLC position in TNGX
TANGO THERAPEUTICS INC · Health Care
TRV GP IV, LLC reported holding 6,374,574 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$120.2M, representing 47.37% of its reported portfolio and ranking #2 among its reported holdings. TRV GP IV, LLC has disclosed TNGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TRV GP IV, LLC's TNGX position evolved
TRV GP IV, LLC first disclosed a stake in TNGX in Q3 2023 at 19,363,975 shares (US$218.0M). Across 12 filings, TRV GP IV, LLC increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 6,374,574 shares valued at US$120.2M. Notable position changes include a 43% trim in Q4 2025 (shares rose 136% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 19.36M | $218.04M | New |
| Q4 2023 | 19.36M | $191.70M | Hold |
| Q1 2024 | 19.20M | $152.46M | Reduce |
| Q2 2024 | 19.20M | $164.75M | Hold |
| Q3 2024 | 16.86M | $129.81M | Reduce |
| Q4 2024 | 16.86M | $52.09M | Hold |
| Q1 2025 | 16.86M | $23.10M | Hold |
| Q2 2025 | 16.86M | $86.32M | Hold |
| Q3 2025 | 13.86M | $116.46M | Reduce |
| Q4 2025 | 7.87M | $69.77M | Reduce |
| Q1 2026 | 6.37M | $133.36M | Reduce |
| Q2 2026 | 6.37M | $120.18M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- RTW INVESTMENTS, LP 13.90M sh · $434.53M · Q2 2026
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 12.28M sh · $383.78M · Q2 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- TCG Crossover Management, LLC 9.08M sh · $283.88M · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $198.74M · Q2 2026
- Siren, L.L.C. 6.18M sh · $193.17M · Q2 2026
- Deep Track Capital, LP 4.20M sh · $131.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- Woodline Partners LP 4.00M sh · $125.06M · Q2 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
More on TRV GP IV, LLC
FAQ
How long has TRV GP IV, LLC held TNGX?
TRV GP IV, LLC has disclosed TNGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is TRV GP IV, LLC's current position in TNGX?
As of Q2 2026, TRV GP IV, LLC holds 6.37M shares of TNGX (TANGO THERAPEUTICS INC), valued at $120.18M, representing 47.37% of its reported portfolio and ranking #2.
Has TRV GP IV, LLC been buying or selling TNGX?
In the latest 13F filing (Q2 2026), TRV GP IV, LLC held unchanged its position in TNGX.
Which other funds hold TNGX?
Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.